Clinical Trial Update: First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Russia evaluating first-line chemotherapy for adults with classical Hodgkin lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | Conditions: Hodgkin Lymphoma, Adult | Phase 3 | Status: RECRUITING